Two cancer immunotherapy drugs, nivolumab and Keytruda, proved remarkably effective against the blood cancer Hodgkin lymphoma in two small, separate studies. The studies add to growing evidence of the potential for enlisting the immune system in the fight against a wide range of tumors. Margaret Shipp, professor of medicine at the Dana Farber Cancer Institute, is a senior co-author of the nivolumab study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?